The US Food and Drug Administration (US FDA) has recently approved Ruconest, the first recombinant C1-Esterase Inhibitor product for the treatment... ...http://www.pharmabiz.com/NewsDetails.aspx?aid=83073&sid=2
A new scalable next generation platelet bioreactor which generates fully functional human platelets in vitro has now been development by a team of... ...http://www.medindia.net/news/human-platelets-successfully-generated-using-next-generation-bioreactor-138991-1.htm
The strength of the immune response determines the seriousness of the disease, rather than with the virus, itself. Turning down that response,... ...http://www.medindia.net/news/immune-response-targeted-with-potential-new-flu-drugs-not-virus-138986-1.htm
Synthetic Biologics, Inc., a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious... ...http://www.pharmabiz.com/NewsDetails.aspx?aid=83068&sid=2
ALLAHABAD: The forensic training offered to the police by MLN Medical College authorities has got delayed, reportedly due to lack of coordination... ...http://timesofindia.indiatimes.com/city/allahabad/Lack-of-coordination-delays-forensic-training-of-police/articleshow/38842056.cms
RAMEL INDUSTRIES LTD. IS A BOOMING...
We are ZEAL and ZEST Solutions Newly...
Indian Association of Preventive &...